Trial Profile
A Double-blind, Randomized, Multi-center Phase III Clinical Trial to Evaluate the Safety and Efficacy of CJ-30060 Compared With Amlodipine/Valsartan Combination Therapy and Valsartan/Rosuvastatin Combination Therapy in Hypertensive Patients With Hyperlipidemia
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 16 Jul 2020
Price :
$35
*
At a glance
- Drugs Amlodipine/rosuvastatin/valsartan (Primary) ; Amlodipine/valsartan; Rosuvastatin/valsartan
- Indications Hyperlipidaemia; Hypertension
- Focus Registrational; Therapeutic Use
- Sponsors CJ HealthCare; HK inno.N
- 29 May 2018 New trial record